BioSystems: Biosystems International and Randox Laboratories Announce Completion of Clinical Trial and Licensing for QuantiPlasma Antibodies for Early Lung Cancer Diagnostics

Biosystems International and Randox Laboratories today announced the beginning of clinical validation of a lung cancer early detection testCRUMLIN NORTHERN IRELAND DEBRECEN HUNGARY PRWEB November 22 2015 Biosystems International and Randox Laboratories t...